Patents by Inventor Mitsugi Yasumoto

Mitsugi Yasumoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5447944
    Abstract: The present invention provides carbamoyl-2 -pyrrolidinone compounds useful as medicaments for improving cerebral functions and activating cerebral metabolism or protecting against anoxic brain damage.
    Type: Grant
    Filed: March 22, 1994
    Date of Patent: September 5, 1995
    Assignee: Taiho Pharmaceutical Company, Limited
    Inventors: Makoto Kajitani, Etsuo Hasegawa, Akihiro Kawaguchi, Junji Yamamoto, Katsuo Toide, Takaji Honna, Mitsugi Yasumoto, Nobuo Kasahara
  • Patent number: 5420117
    Abstract: This invention provides a 5-substituted uridine derivative of the formula ##STR1## wherein X is F or CF.sub.3, R.sub.1 and R.sub.2 each represent a group --OSi--(R.sub.4)(R.sub.5)(R.sub.6) (wherein R.sub.4, R.sub.5 and R.sub.6 represent C.sub.1 -C.sub.10 alkyl or the like), OH, aminoacyloxy group wherein the amino group may be substituted with lower alkyl group or carboxylalkylcarbonyloxy group, R.sub.3 is a group --OSi(R.sub.4)(R.sub.5)(R.sub.6), H, OH, aminoacyloxy group wherein the amino group may be substituted with lower alkyl group, or carboxylalkylcarbonyloxy group, and at least one of R.sub.1, R.sub.2 and R.sub.3 is a group --OSi--(R.sub.4)(R.sub.5)(R.sub.6), with the proviso that when X is fluorine atom, R.sub.3 is not hydrogen, and an intermediate for the preparation thereof, preparation processes of the derivative and anti-tumor agent containing the derivative as an active ingredient.
    Type: Grant
    Filed: October 19, 1992
    Date of Patent: May 30, 1995
    Assignee: Taiho Pharmaceutical Co., Ltd.
    Inventors: Tadafumi Terada, Katsuhiko Fujimoto, Junichi Yamashita, Mitsugi Yasumoto, Setsuo Takeda, Junji Uchida, Konstanty Wierzba, Yuji Yamada
  • Patent number: 5318970
    Abstract: A isoxazole compound represented by the formula (1): ##STR1## wherein R represents a hydrogen atom or a lower alkoxy group, R.sub.1 is a group represented by the formula (2): ##STR2## (wherein A represents --NH-- or --O--, B represents a methylene group or a carbonyl group, m is 0 or 1, n is an integer of 1 to 12, X represents a hydrogen atom, a hydroxy group or a lower alkoxycarbonyl group, Y represents a phenyl group which can be substituted with one or more halogen atoms, or a hydrogen atom), a group represented by the formula (3): ##STR3## (wherein Z represents a pyrimidinyl group), or a group represented by the formula (4): ##STR4## (wherein R.sub.2 represents a styryl group which can be substituted with one or more hydroxy groups); a pharmaceutically acceptable salt thereof; or a medical use thereof in a method of inhibiting lipoxygenase, inhibiting 5-lipoxygenase or inhibiting cyclooxygenase.
    Type: Grant
    Filed: March 17, 1993
    Date of Patent: June 7, 1994
    Assignee: Taiho Pharmaceutical Co., Ltd.
    Inventors: Masahiro Suzuki, Kenji Nozaki, Makoto Kajitani, Mitsugi Yasumoto, Naohiko Ono, Takashi Shindo
  • Patent number: 5310926
    Abstract: The present invention provides a process for producing isoxazole derivatives represented by the formula ##STR1## wherein R.sup.1 and R.sup.2 are the same or different and are each a hydrogen atom or lower alkoxyl, and R.sup.3 is cyano or alkoxycarbonyl, the process being characterized by oxidizing an .alpha., .beta.-unsaturated ketoxime derivative represented by the formula ##STR2## wherein R.sup.1 , R.sup.2 and R.sup.3 are as defined above. The isoxazole derivatives (II) to be produced by the process of the present invention are useful as intermediates for preparing (3,4-diarylisoxazol-5-yl) acetic acid derivatives which are useful as anti-inflammatory agents, analgesics and antipyretics.
    Type: Grant
    Filed: September 16, 1993
    Date of Patent: May 10, 1994
    Assignee: Taiho Pharmaceutical Co., Limited
    Inventors: Yu-ichi Hagiwara, Motoaki Tanaka, Makoto Kajitani, Mitsugi Yasumoto
  • Patent number: 5250673
    Abstract: Novel 2'-deoxy-5-substituted uridine derivative represented by the general formula, ##STR1## wherein R.sub.1 is a hydrogen atom, a benzoyl group or a tetrahydrofuranyl group; R.sub.2 is a fluorine atom or a trifluoromethyl group; and any one of R.sub.3 and R.sub.4 is a hydrogen atom and the other one is an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a benzyl group having as the substituents selected from the group consisting of a halogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms and a nitro group, or an alkyl group having 1 to 3 carbon atoms having one or two phenyl groups as the substituents.The novel 2'-deoxy-5-substituteduridine derivative possesses excellent antitumor activity with less toxicity, thus it is useful as antitumor agent.
    Type: Grant
    Filed: October 17, 1989
    Date of Patent: October 5, 1993
    Assignee: Taiho Pharmaceutical Company, Ltd.
    Inventors: Setsuro Fujii, Jun-ichi Yamashita, Hiroshi Matsumoto, Setsuo Takeda, Tadafumi Terada, Mitsugi Yasumoto, Norio Unemi
  • Patent number: 5229402
    Abstract: The present invention provides a carbamoyl-2-pyrrolidinone compound which has the following formula (2) and is useful as medicaments for treating senile dementia, i.e., as cerebral function improving agents and cerebral metabolism activators or anoxic brain damage protectives ##STR1## wherein R.sup.1 is a hydrogen atom, hydroxyl or lower alkyl substituted or unsubstituted with hydroxyl, and R.sup.3 is phenyl, tetrahydronaphthyl, pyridyl or thiazolyl having or not having lower alkoxyl, lower alkylamino, a halogen atom or halogenomethyl as a substituent.Further, the present invention provides novel carbamoyl-2-pyrrolidinone compounds represented by the formula ##STR2## wherein R.sup.1 is a hydrogen atom, hydroxyl or lower alkyl substituted or unsubstituted with hydroxyl, and R.sup.2 is phenyl, tetrahydronaphthyl, pyridyl or thiazolyl having or not having methoxy or lower alkylamino as a substituent, provided that when R.sup.1 is a hydrogen atom or unsubstituted lower alkyl, R.sup.2 is not unsubstituted phenyl.
    Type: Grant
    Filed: December 13, 1989
    Date of Patent: July 20, 1993
    Assignee: Taiho Pharmaceutical Company, Ltd.
    Inventors: Makoto Kajitani, Etsuo Hasegawa, Akihiro Kawaguchi, Junji Yamamoto, Katsuo Toide, Takaji Honna, Mitsugi Yasumoto, Nobuo Kasahara
  • Patent number: 5214039
    Abstract: The present invention provides a bicyclolactam derivative which has the following formula and is useful as medicaments for treating senile dementia, i.e., as cerebral function improving agents and cerebral metabolism activators or anoxic brain damage protectives ##STR1## wherein R is benzoyl group which may be substituted with halogen atom, lower alkyl group, lower alkoxyl group, nitro group, cyano group or amino group; l is 1 or 2; m is 0 or 1; and n is 0, 1 or 2, provided that m and n are not 0 at the same time.
    Type: Grant
    Filed: August 5, 1992
    Date of Patent: May 25, 1993
    Assignee: Taiho Pharmaceutical Co., Limited
    Inventors: Akihiro Kawaguchi, Atsushi Satoh, Makoto Kajitani, Mitsugi Yasumoto, Junji Yamamoto
  • Patent number: 5206261
    Abstract: The present invention provides an oxindole derivative which has the following formula and is useful as medicaments for treating senile dementia, i.e., as cerebral function improving agents and cerebral metabolism activators or anoxic brain damage protectives ##STR1## wherein R.sup.1 is hydrogen atom, halogen atom, lower alkyl group or lower alkoxyl group, R.sup.2 is hydrogen atom or lower alkyl group, R.sup.3 is --CH.sub.2 --R.sup.5 group (R.sup.5 being alkyl group which may form a ring; benzodioxanyl group; or phenyl group which may have plural substituents selected from among halogen atom, lower alkyl group, lower alkoxyl group, hydroxyl group, diethylamino group, trifluoromethyl group, nitrile group, nitro group and benzyloxy group), R.sup.2 and R.sup.3 may form together .dbd.CH--R.sup.5 (R.sup.5 being same as above), R.sup.
    Type: Grant
    Filed: March 20, 1991
    Date of Patent: April 27, 1993
    Assignee: Taiho Pharmaceutical Company, Limited
    Inventors: Akihiro Kawaguchi, Atsushi Sato, Makoto Kajitani, Mitsugi Yasumoto, Junji Yamamoto
  • Patent number: 5185344
    Abstract: The present invention provides a bicyclolactam derivative which has the following formula and is useful as medicaments for treating senile dementia, i.e., as cerebral function improving agents and cerebral metabolism activators or anoxic brain damage protectives ##STR1## wherein R is benzoyl group which may be substituted with halogen atom, lower alkyl group, lower alkoxyl group, nitro group, cyano group or amino group; l is 1 or 2; m is 0 or 1; and n is 0, 1 or 2, provided that m and n are not 0 at the same time.
    Type: Grant
    Filed: October 1, 1991
    Date of Patent: February 9, 1993
    Assignee: Taiho Pharmaceutical Company, Ltd.
    Inventors: Akihiro Kawaguchi, Atsushi Satoh, Makoto Kajitani, Mitsugi Yasumoto, Junji Yamamoto
  • Patent number: 5182284
    Abstract: Disclosed are a piperazine compound of the formula below or a pharmaceutically acceptable salt thereof, medical uses thereof, and processes for preparing the same: ##STR1## wherein each of R and R' is --OH, a lower alkoxy, a halo, H, a di(lower alkyl) hydrogenphosphate residue or a group --OR" (R" is an aralkyl group, etc.), etc., Y is --CH.dbd.CH-- or --(CH.sub.2).sub.m -- (m is 0, 1 or 2), and Y.sub.1 is a group of the formula ##STR2## (wherein A is --NH-- or --O--, A.sub.1 is a methylene or a carbonyl, n is 6-20, X is --OH, H or a lower alkoxycarbonyl, and X.sub.1 is an optionally halo-substituted phenyl or H) or a group of the formula ##STR3## (wherein X and n are as defined above), provided that when Y.sub.1 is the group of the formula (3), each of R and R' is an --OH group.
    Type: Grant
    Filed: September 25, 1991
    Date of Patent: January 26, 1993
    Assignee: Taiho Pharmaceutical Co., Ltd.
    Inventors: Masahiro Suzuki, Kenji Nozaki, Makoto Kajitani, Mitsugi Yasumoto, Naohiko Ono, Takashi Shindo
  • Patent number: 5142091
    Abstract: The present invention provides an .alpha., .beta.-unsaturated ketone and ketoxime derivative represented by the formula ##STR1## wherein Y is oxygen atom or hydroxyimino group, Z is cyano or alkoxycarbonyl group, R.sup.1 and R.sup.2 are the same or different and are each hydrogen atom or lower alkoxyl group.The .alpha., .beta.-unsaturated ketones and ketoxime derivatives of the invention are useful as an intermediate for preparing a (3,4-diarylisoxazol-5-yl)acetic acid derivatives which is useful as an anti-inflammatory agent, analgesic and antipyretic.
    Type: Grant
    Filed: July 10, 1991
    Date of Patent: August 25, 1992
    Assignee: Taiho Pharmaceutical Company Limited
    Inventors: Motoaki Tanaka, Yu-ichi Hagiwara, Makoto Kajitani, Mitsugi Yasumoto
  • Patent number: 5068235
    Abstract: The present invention provides a diazabicycloalkane derivative which has the following formula and is useful as medicaments for treating senile dementia, i.e., as cerebral function improving agents and cerebral metabolism activators or anoxic brain damage protectives ##STR1## wherein R.sup.1 is phenyl group, thiazolyl group or furyl group, the phenyl group may have lower alkoxy, lower alkyl or halogen atom as a substituent, R.sup.2 is oxygen atom or sulfur atom, m is 3 or 4, n is 1 or 2.
    Type: Grant
    Filed: August 16, 1990
    Date of Patent: November 26, 1991
    Assignee: Taiho Pharmaceutical Company, Limited
    Inventors: Etsuo Hasegawa, Akihiro Kawaguchi, Makoto Kajitani, Mitsugi Yasumoto, Nobuo Kasahara, Junji Yamamoto
  • Patent number: 4946951
    Abstract: Disclosed is a 2'-deoxy-5-fluorouridine derivative of the formula ##STR1## wherein one of R.sub.1 and R.sub.2 is a benzyl group which may optionally have substituent selected from the group consisting of C.sub.1 -C.sub.6 alkyl group, C.sub.1 -C.sub.6 alkoxy group, C.sub.1 -C.sub.3 halogenated alkyl group, halogen atom, hydroxyl group and nitro group on the phenyl ring, and the other constitutes an amino acid residue, or a salt thereof. The compounds are useful for treating cancer.
    Type: Grant
    Filed: July 29, 1988
    Date of Patent: August 7, 1990
    Assignee: Taiho Pharmaceutical Co., Ltd.
    Inventors: Yukio Tada, Atsuhiko Uemura, Mitsugi Yasumoto, Setsuo Takeda, Hitoshi Saito, Norio Unemi
  • Patent number: 4886877
    Abstract: Novel 2'-deoxy-5-substituted uridine derivative represented by the general formula, ##STR1## wherein R.sub.1 is a hydrogen atom, a benzoyl group or a tetrahydrofuranyl group; R.sub.2 is a fluorine atom or a trifluoromethyl group; and any one of R.sub.3 and R.sub.4 is a hydrogen atom and the other one is an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a benzyl group having as the substituents selected from the group consisting of a halogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms and a nitro group, or an alkyl group having 1 to 3 carbon atoms having one or two phenyl groups as the substituents.The novel 2'-deoxy-5-substituteduridine derivative possesses excellent antitumor activity with less toxicity, thus it is useful as antitumor agent.
    Type: Grant
    Filed: February 26, 1988
    Date of Patent: December 12, 1989
    Assignee: Taiho Pharmaceutical Company Limited
    Inventors: Setsuro Fujii, Jun-ichi Yamashita, Hiroshi Matsumoto, Setsuo Takeda, Tadafumi Terada, Mitsugi Yasumoto, Norio Unemi
  • Patent number: 4696929
    Abstract: A piperazine derivative represented by the formula (I) below ##STR1## wherein R.sup.1 is lower alkyl or phenyl, R.sup.2 is hydrogen or lower alkyl, n is an integer of 2 to 10, is useful as an effective component of anti-inflammatory agent or antiallergic agent.
    Type: Grant
    Filed: December 17, 1985
    Date of Patent: September 29, 1987
    Assignee: Taiho Pharmaceutical Company, Limited
    Inventors: Ichiro Yamawaki, Kazuo Ogawa, Naohiko Ono, Takaji Honna, Sekio Nagayama, Mitsugi Yasumoto
  • Patent number: 4670583
    Abstract: This invention provides an amide compound represented by the formula ##STR1## wherein R.sub.1 is vinyl, 2-(methylsulfinyl)ethyl, 2-(methylsulfonyl)ethyl, 2-(2-acetylamino-2-carboxyethylthio)ethyl or 2-[2-(4-amino-4-carboxybutyrylamino)-2-(carboxymethylcarbamoyl)ethylthio]e thyl and R.sub.2 is hydrogen or lower alkyl, process for the preparation thereof, and antiallergic compositions cotaining the amide compound.
    Type: Grant
    Filed: September 5, 1985
    Date of Patent: June 2, 1987
    Assignee: Taiho Pharmaceutical Company, Limited
    Inventors: Akihide Koda, Mikio Hori, Mitsugi Yasumoto, Naosuke Matsuura, Ichiro Yamawaki, Yukio Tada
  • Patent number: 4581372
    Abstract: Sulfonium compounds represented by the formula ##STR1## having immunostimulant activity and useful as the active components of drugs and agricultural chemicals.
    Type: Grant
    Filed: October 14, 1983
    Date of Patent: April 8, 1986
    Assignee: Taiho Pharmaceutical Company Limited
    Inventors: Akihide Koda, Mikio Hori, Mitsugi Yasumoto, Ichiro Yamawaki, Yuji Yamada, Katsuo Takikawa
  • Patent number: 4556737
    Abstract: This invention provides novel sulfonium compounds, processes for the preparation of the sulfonium compounds, and pharmacological composition containing the sulfonium compound. The compounds of this invention are useful for treating allergy.
    Type: Grant
    Filed: February 27, 1984
    Date of Patent: December 3, 1985
    Assignee: Taiho Pharmaceutical Company Limited
    Inventors: Akihide Koda, Mikio Hori, Naosuke Matsuura, Mitsugi Yasumoto, Ichiro Yamawaki, Shuichi Ueda, Yukio Tada
  • Patent number: 4340543
    Abstract: Sulfonium compounds represented by the formula ##STR1## have anticancer activity, immunostimulant activity and the like, and useful as the active components of drugs and agricultural chemicals.
    Type: Grant
    Filed: February 3, 1981
    Date of Patent: July 20, 1982
    Assignee: Taiho Pharmaceutical Company Limited
    Inventors: Akihide Koda, Mikio Hori, Mitsugi Yasumoto, Ichiro Yamawaki, Yuji Yamada, Katsuo Takikawa